arrow
K

Kazunari Sasaki

stanford university school of medicine
H指数:41
被引数:6,476
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk- adjusted Cumulative Sum (RA-CUSUM) method for real time monitoring of surgical units performance.

风险调整的累积和(RA-CUSUM)方法用于外科单元绩效的实时监测

HPB
IF2.4
2026-05-060
PRE
Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasis

早期与晚期结直肠癌肝转移行切除术患者的临床病理特征、基因组特征及预后

Surgery
IF2.7
2025-11-280
PRE
Development and validation of a machine-learning model to reduce futile procurements in donations after circulatory death in liver transplantation in the USA: a multicentre study

开发和验证一种机器学习模型以减少美国肝移植中心死亡后器官捐献的无效获取:一项多中心研究

2025-11-130
OAAI
Time-varying hazards of recurrence patterns among patients with colorectal liver metastases undergoing liver resection and the role of the modified Tumor Burden Score

结直肠癌肝转移患者行肝切除术后复发模式的时间变化风险及改良肿瘤负荷评分的作用

2025-10-200
PRE
Textbook outcome in liver surgery after staged versus simultaneous resection for synchronous colorectal liver metastases

同步结直肠癌肝转移分期切除与同时切除后肝脏手术教科书式结局的比较

HPB
IF2.4
2025-04-290
PRE
Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles

在行肝切除术的结直肠癌肝转移患者中增强预后预测:FIB-4指数与肿瘤负荷评分在KRAS谱系中的协同影响

HPB
IF2.4
2025-04-140
PRE
ASO Visual Abstract: The Composite Endpoint of Liver Surgery CELS-Development and Validation of a Clinically Relevant Endpoint Requiring Lower Sample Size
2025-03-010
PRE
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size
2025-01-311
OAAI